Intravenous thrombolysis in patients with stroke attributable to small artery occlusion 
. Treatment response seems to be independent of the underlying stroke mechanism 2 . However, whether this is also true for stroke attributable to small artery occlusion (SAO) is unclear: Theoretically, the pathogenetic mechanism of SAO-stroke may not be susceptible to reperfusion 3 . In practice, few patients in the placebo-controlled randomized IVT-trials had strokes due to SAO 4 , though this etiology accounts for up to 16% to 23% of all ischemic strokes 5, 6 . Moreover, in recent case series, lacunar stroke patients treated with IVT are at a particular risk for early deterioration 7 and seem to carry a poorer functional prognosis than IVT-treated patients with non-lacunar strokes 8 . In addition, leukoaraiosis is frequent in SAOpatients 9 .
As leukoaraiosis is a risk factor for symptomatic intracranial hemorrhage (ICH) after IVT [10] [11] [12] , the bleeding risk in SAO-patients may be higher than in patients with stroke etiologies other than SAO.(i.e., non-SAO-patients).
With these considerations in mind, we aimed at evaluating, whether the variable "stroke etiology SAO" has a prognostic meaning in IVT-treated patients. Specifically, we analyzed and compared outcome and complications of SAO and non-SAO-patients using pooled data of Swiss stroke centers.
Methods:
As a joint initiative of 9 stroke centers in Switzerland, we designed a study about the significance of SAO as underlying stroke etiology in IVT-treated patients. All participating centers (5 university hospitals, 4 community hospitals) used IVT according to current guidelines 13 . Data were collected with a standardized form with predefined variables as it was also used in a previous study with similar methodology 14 . Local study participants filled in the forms systematically using prospectively ascertained in-hospital stroke databases or thrombolysis-registries. The completed forms of all centers were compiled in the coordinating center Basel, where the analyses of the pooled data were performed. The following variables were ascertained: Age, gender, functional independence prior to thrombolysis, time-to-treatment, stroke severity as assessed by the Each center reported on the period for which they had prospectively ascertained data on consecutive patients up to December 31 st 2007 . The appendix provides detailed data about the number of patients and the study period for each center. For the current study, all IVT-treated stroke patients were categorized according to the underlying etiology 16 as SAO and non-SAOpatients. In detail, the etiological diagnosis SAO based on the presence of a lacunar syndrome and neuroimaging findings comparable with a small lacunar infarction in the territory of basal or brainstem penetrating arteries and in the absence of steno-occlusive diseases of the parent artery or a cardioembolic disease 16, 17 . Patients with two etiologies from which one was SAO were excluded from the analyses.
Main outcome measures were (i) 3-month outcome assessed as the rate of patients being independent (mRS 2), and those being dead, (ii) ICH (asymptomatic, symptomatic, fatal) 1 , and (iii) recurrent ischemic stroke within 3 months.
For the subgroup of SAO-patients, predictors for a favorable outcome were sought. In detail SAOpatients with functional independence after 3 months were compared with those being dependent or death with respect to baseline characteristics.
Statistical analysis
After data pooling, comparisons of SAO-and non-SAO patients were done using t-and chi-square tests. Data were given as mean and standard deviation (SD). The prognostic importance of the variable "SAO" was estimated by calculating odds ratios (OR) with 95% confidence intervals (95% CI) for each outcome variable (i.e., mRS2, ICH, death, recurrent ischemic stroke). In a second step, the OR for favorable 3-month outcome was adjusted for age 14, 18 , gender 18 , and NIHSS-scores 18, 19 by multivariable regression analysis. Analyses were performed using the SPSS statistical package (SPSS for Windows, version 15.0).
Results

Study population
Among 1085 IVT-treated patients, 1048 (96.7%) fulfilled the eligibility criteria. Out of them, 65 (6.2%) had SAO as stroke etiology, whereas 983 (93.8%) had another etiology. Both, the non-SAO-and the SAO-patients had similar intervals to thrombolysis (153±37 versus 153±44).
Comparing non-SAO-with SAO-patients, NIHSS score (mean 13.1±6.0 versus 9.1±4.6; median 13 versus 8; p <0.001) and systolic blood pressure (mean 175±28 versus 155±27mmHg; <0.001)
were significantly higher in non-SAO-patients. Smoking was more often found in SAO-patients (42.6% versus 23.9%, p<0.001) while coronary artery disease and atrial fibrillation was more common in non-SAO-patients (details see Table 1 ).
In the SAO-group, Table 2 ).
The rates of ICH (all, symptomatic) did not differ between SAO (12.3%, 4.6%) and non-SAOpatients (13.4%, 5.3%; (p>0.8). Fatal ICH occurred in 3.3% of the non-SAO-patients but were absent among SAO-patients. Recurrent ischemic events occurred in one of the SAO-patients (1.5% 95%CI: 0.04-8.3%) versus 23 of the non-SAO-patients (2.3%). (Table 1) .
SAO-patients who reached independence after 3 month differed from SAO-patients who were dependent or dead in lower mean glucose levels (7.1±3.2 versus 7.9±24.2, p=0.03) and a trend towards lower mean NIHSS-scores (8.5±4.5 versus 11.1±4.5; p=0.06). All other variables showed no difference between both outcome groups ( Table 3) .
Discussion
This study yielded the following main findings: 1) among IVT treated stroke patients, SAOpatients had a better functional outcome than non-SAO-patients, 2) after adjustment for age, NIHSS-score, and gender, "SAO" was no longer significantly associated with functional independence, 3) SAO-patients did not carry an ICH risk higher than that of non-SAO-patients.
Seventy-five percent of the SAO-patients treated with IVT reached functional independence after 3 months. Thus, taking into account the 95%CI (i.e., 63%-85%), 4 to 5 out of 6 SAO-patients can be expected to become functionally independent after IVT. This rate does not exceed that of SAO-patients in a population-based study not treated with IVT (i.e., mRS 0-2 after 3 moths was 84.7%) 6 . However, population-based studies include also patients with stroke too mild to justify IVT. Thus, differing eligibility criteria do not allow for a one-to-one comparison with the current study.
More importantly, IVT-treated SAO-patients had -unadjusted -a better outcome than IVTtreated non-SAO-patients. The observation, that the association between functional independence and SAO lost statistical significance after adjustment indicates that the prognostic variables "age" 14, 18 , and "stroke severity" 18, 19 are more important than stroke etiology being SAO. In addition, the adjusted point estimate of 1.41 indicates that IVT-treated SAO-patients are unlikely to have a worse prognosis than non-SAO-patients, despite reports about the risk of early neurological deterioration in IVT-treated SAO-patients 7 .
In IVT-treated SAO-patients, initial glucose levels and (to some degree) stroke severities were associated with functional independence after 3 months. Thus, glucose 20 and NIHSS-scores 18, 19 as outcome predictors in IVT-treated populations of miscellaneous stroke etiologies were also predictive in the subgroup of SAO-patients, while age was not.
ICH occurred rarely in IVT-treated SAO-patients. The rate of symptomatic ICH was slightly lower than those for all IVT-treated patients reported in the NINDS (i.e. 6.4%) 1 and the ECASS-3 (i.e. 21 studies adhering to the same definition.
7.9%)
Moreover, intracranial bleedings rates were comparable in SAO-and non-SAO-patients. The absence of an increased ICH risk among SAO-patients is important because leukoaraiosis as a risk factor for IVT-associated ICH 11,22 is frequent in SAO-patients 9 . Thus, among IVT-treated patients, SAO-patients seem not to harbour an increased ICH risk.
As a limitation, only 6% in this IVT-treated cohort had SAO as stroke etiology. This may suggest a selection bias, while in general a rate of 16% to 23% 5, 6 SAO-patients is expected. Nevertheless, among the 90 IVT-patients reported by Hsia et al.
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less likely to receive IVT. Potential reasons include less severe strokes and late presentation 23, 24 .
More importantly, we did not compare the outcome of IVT-treated SAO-patients with that of SAOpatients not treated with IVT. Thus, the study design disallows us to answer the question, whether SAO-patients benefit from IVT. This question has to await the results of a randomized controlled trial (e.g. the IST-3 study 25 ). However, our findings indicate a certain safety of IVT in SAOpatients.
In conclusion, IVT treated SAO-patients reached functional independence more often than IVT treated non-SAO-patients do. However, the variable "SAO" was a dependent rather than an independent outcome predictor. The trend towards a better outcome in SAO-patients as compared to non-SAO-patients and the absence of an excess in ICH suggest that IVT seems not to be harmful in SAO-patients. 
